-
1 Comment
ChemoCentryx, Inc is currently in a long term downtrend where the price is trading 67.5% below its 200 day moving average.
From a valuation standpoint, the stock is 96.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 51.9.
ChemoCentryx, Inc's total revenue sank by 55.9% to $4M since the same quarter in the previous year.
Its net income has dropped by 92.4% to $-30M since the same quarter in the previous year.
Finally, its free cash flow fell by 38.6% to $-28M since the same quarter in the previous year.
Based on the above factors, ChemoCentryx, Inc gets an overall score of 1/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| Sector | Financial Services |
| Industry | Shell Companies |
| ISIN | None |
| Beta | nan |
|---|---|
| Market Cap | 571M |
| Target Price | None |
| PE Ratio | None |
| Dividend Yield | None |
Churchill Capital Corp XI does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CCXI using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
